Gewuzhihe is a brain disease detection and product developer, focusing on the fields of brain science and oncology, and is committed to the research of multi-omics platforms such as cytoomics, proteomics, and genomics. Combining AI image recognition technology with blockchain and big data analysis, develop and industrialize a series of automated diagnostic testing instruments and supporting reagents to gain in-depth insight into the analysis of cell groups, proteomes, metabolomes, genomes and other health information. From early warning and prevention, to precise diagnosis, and then to individualized treatment, we provide innovative technology products and services in the whole process. Recently, it has completed a round of financing of nearly 100 million yuan, which was jointly led by Yuanhe Yuandian and Xingze Capital, and Capital Capital served as the exclusive financial advisor. The funds raised in this round of financing will be mainly used for the continuous research and development of the company’s series of independent innovation technology platforms in the direction of proteomics and spatial omics, and to accelerate the independent research and development of a new generation of ultra-sensitive single-molecule protein detection systems and related neurodegenerative disease markers Development and registration of biological detection kits.
This article is reproduced from: https://www.itjuzi.com/investevent/13287935
This site is for inclusion only, and the copyright belongs to the original author.